Back to companies

Allogene Therapeutics Inc: Executives

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

The following section provides information on Allogene Therapeutics Inc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Allogene Therapeutics Inc's management and employees, unlock the full data with our company analytics monitoring tool.

Executives

Arie Belldegrun, M.D.

Chairman Executive Board Since: 2017 Age: 75

David Chang, M.D., Ph.D.

Director; President; Chief Executive Officer Executive Board Since: 2018 Age: 65

Geoffrey Parker

Chief Financial Officer; Executive Vice President Senior Management Since: 2023 Age: 60

Christine Cassiano

Chief Communications Officer; Chief Corporate Affairs and Brand Strategy Officer; Executive Vice President Senior Management

Susie Lundeen

Chief People Officer Senior Management
Gain a 360-degree view of Allogene Therapeutics Inc and make more informed decisions for your business Gain a 360-degree view of Allogene Therapeutics Inc and make more informed decisions for your business Register your interest
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer